Edesa Biotech, Inc.
EDSA
$7.69
$0.699.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.58M | 4.24M | 3.90M | 3.97M | 3.86M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.35M | 7.91M | 6.45M | 6.47M | 7.06M |
| Operating Income | -8.35M | -7.91M | -6.45M | -6.47M | -7.06M |
| Income Before Tax | -7.82M | -7.18M | -5.92M | -5.84M | -6.11M |
| Income Tax Expenses | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 |
| Earnings from Continuing Operations | -7.82 | -7.19 | -5.92 | -5.84 | -6.11 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.82M | -7.19M | -5.92M | -5.84M | -6.11M |
| EBIT | -8.35M | -7.91M | -6.45M | -6.47M | -7.06M |
| EBITDA | -8.25M | -7.79M | -6.31M | -6.31M | -6.87M |
| EPS Basic | -1.15 | -1.35 | -1.33 | -1.60 | -1.88 |
| Normalized Basic EPS | -0.77 | -0.94 | -0.92 | -1.11 | -1.35 |
| EPS Diluted | -1.15 | -1.35 | -1.33 | -1.60 | -1.88 |
| Normalized Diluted EPS | -0.77 | -0.94 | -0.92 | -1.11 | -1.35 |
| Average Basic Shares Outstanding | 27.36M | 22.73M | 18.92M | 15.12M | 13.01M |
| Average Diluted Shares Outstanding | 27.36M | 22.73M | 18.92M | 15.12M | 13.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |